Clinical trial for COVID-19 vaccine opening in Gulfport
The National Institute of Allergy and Infectious Diseases is sponsoring a clinical trial for COVID-19 patients in Gulfport. The ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial is open for enrollment. Its primary goal is to determine whether investigational agents…